Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy R Seiler, HAD Ashab, N Erho, BWG van Rhijn, B Winters, J Douglas, ... European urology 72 (4), 544-554, 2017 | 816 | 2017 |
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis SG Zhao, SL Chang, DE Spratt, N Erho, M Yu, HAD Ashab, M Alshalalfa, ... The lancet oncology 17 (11), 1612-1620, 2016 | 224 | 2016 |
Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome S You, BS Knudsen, N Erho, M Alshalalfa, M Takhar, H Al-deen Ashab, ... Cancer research 76 (17), 4948-4958, 2016 | 181 | 2016 |
Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies R Stoyanova, A Pollack, M Takhar, C Lynne, N Parra, LLC Lam, ... Oncotarget 7 (33), 53362, 2016 | 122 | 2016 |
An augmented reality system for epidural anesthesia (AREA): prepuncture identification of vertebrae HAD Ashab, VA Lessoway, S Khallaghi, A Cheng, R Rohling, ... IEEE transactions on biomedical engineering 60 (9), 2636-2644, 2013 | 38 | 2013 |
Development and validation of a prostate cancer genomic signature that predicts early ADT treatment response following radical prostatectomy RJ Karnes, V Sharma, V Choeurng, HAD Ashab, N Erho, M Alshalalfa, ... Clinical Cancer Research 24 (16), 3908-3916, 2018 | 28 | 2018 |
Real-time ultrasound image classification for spine anesthesia using local directional Hadamard features M Pesteie, P Abolmaesumi, HAD Ashab, VA Lessoway, S Massey, ... International journal of computer assisted radiology and surgery 10, 901-912, 2015 | 27 | 2015 |
AREA: an augmented reality system for epidural anaesthesia HAD Ashab, VA Lessoway, S Khallaghi, A Cheng, R Rohling, ... 2012 Annual International Conference of the IEEE Engineering in Medicine and …, 2012 | 19 | 2012 |
Use of a genetic signature diagnostically to evaluate treatment strategies for prostate cancer HAD Ashab, N Erho, M Alshalalfa, E Davicioni US Patent App. 15/765,711, 2018 | 10 | 2018 |
Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies. Oncotarget. 2016; 7: 53362–76 R Stoyanova, A Pollack, M Takhar, C Lynne, N Parra, LL Lam, ... DOI: https://doi. org/10.18632/oncotarget 10523, 53362, 2012 | 9 | 2012 |
Multimodal classification of prostate tissue: a feasibility study on combining multiparametric MRI and ultrasound HAD Ashab, NF Haq, G Nir, P Kozlowski, P Black, EC Jones, ... Medical Imaging 2015: Computer-Aided Diagnosis 9414, 334-343, 2015 | 7 | 2015 |
Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness E Davicioni, N Erho, HAD Ashab, M Alshalalfa US Patent 11,078,542, 2021 | 6 | 2021 |
Relationships between an androgen receptor output signature (ARoS), AR expression, and poor prostate cancer prognosis in RP tissues. M Alshalalfa, M Santiago-Jimenez, N Erho, N Fishbane, K Yousefi, ... Journal of Clinical Oncology 35 (6_suppl), 38-38, 2017 | 5 | 2017 |
Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy. DT Miyamoto, E Gibb, KW Mouw, Y Liu, CL Wu, M Drumm, J Lehrer, ... Journal of Clinical Oncology 36 (6_suppl), 513-513, 2018 | 4 | 2018 |
Solutions for missing parameters in computer-aided diagnosis with multiparametric imaging data HAD Ashab, P Kozlowski, SL Goldenberg, M Moradi Machine Learning in Medical Imaging: 5th International Workshop, MLMI 2014 …, 2014 | 4 | 2014 |
Ultrasound guidance for epidural anesthesia HAD Ashab University of British Columbia, 2013 | 4 | 2013 |
Subtyping muscle-invasive bladder cancer to assess clinical response to trimodality therapy JA Efstathiou, E Gibb, DT Miyamoto, CL Wu, MR Drumm, J Lehrer, ... International Journal of Radiation Oncology, Biology, Physics 99 (2), S118, 2017 | 3 | 2017 |
A 24-gene predictor of response to postoperative radiation therapy in prostate cancer SG Zhao, SL Chang, DE Spratt, NG Erho, M Yu, H Ashab, K Yousefi, ... International Journal of Radiation Oncology, Biology, Physics 96 (2), S104-S105, 2016 | 3 | 2016 |
OC-0049: Genomic profiling of muscle invasive bladder cancer to predict response to chemoradiation therapy D Miyamoto, E Gibb, K Mouw, Y Liu, C Wu, M Drumm, J Lehrer, H Ashab, ... Radiotherapy and Oncology 127, S21, 2018 | 2 | 2018 |
Muscle invasive bladder cancer: a single sample patient assay to predict molecular subtypes and benefit of neoadjuvant chemotherapy R Seiler, HAD Ashab, N Erho, BW Van Rhijn, B Winters, J Douglas, ... European Urology Supplements 3 (16), e1567-e1568, 2017 | 2 | 2017 |